Market Place
Sourcing Support
Macleods Pharma`s Generics Canagliflozin Receives Tentative Approval in US
06 Aug 2024 //
FDA
USFDA approves Zydus Canagliflozin and Metformin Hydrochloride tablets
20 Feb 2023 //
HEALTH ET
Zydus receives USFDA tentative approval for Canagliflozin Tablet
16 Feb 2023 //
BUSINESS STANDARD
Zydus` Generic Canagliflozin Receives Approval in the U.S.
13 Feb 2023 //
FDA
Laurus Labs` Generic Canagliflozin Receives Approval in the U.S.
28 Jan 2022 //
FDA
Heart failure symptoms improved with a type 2 diabetes medicine
15 Nov 2021 //
NEWSROOM
Acute heart failure patients benefit with type 2 diabetes medication
14 Nov 2021 //
NEWSROOM
J&J looks to toss its SGLT2 hat in the ring for two types of heart failure
14 Nov 2021 //
ENDPTS
KidneyIntelX™ Enables Monitoring of SGLT2 Inhibitor Therapy Response
28 Jun 2021 //
GLOBENEWSWIRE
Canagliflozin (TA-7284) has been approved in Taiwan For Diabetic Nephropathy
25 Feb 2021 //
PRESS RELEASE
New Study Offers Hope for Patients with Diabetes and Advanced Kidney Disease
21 Sep 2020 //
PRNEWSWIRE
AstraZeneca`s Farxiga cuts kidney disease risks by 39% in trial
30 Aug 2020 //
FIERCE PHARMA
FDA pulls J&J`s Invokana boxed amputation risk warning
28 Aug 2020 //
FIERCE PHARMA
FDA: Amputation risk boxed warning removed from canagliflozin
26 Aug 2020 //
HEALIO
Europe extends Invokana indication to cover diabeticKD in type 2 diabetes
03 Jul 2020 //
PHARMAFILE
Napp Pharmaceuticals Announces European Commission Approval of Invokana®
02 Jul 2020 //
BUSINESSWIRE
Napp Announces European Commission Approval of Invokana® (canagliflozin)
01 Jul 2020 //
BUSINESSWIRE
CHMP Issues Positive Opinion to Extend Invokana® (Canagliflozin)
29 May 2020 //
YAHOO
Janssen`s INVOKANA Gets Boost Over Competitors with FDA Approval
27 Nov 2019 //
PR NEWSWIRE
CREDENCE Study Shows the Efficacy and Safety Profiles INVOKANA® (canagliflozin)
11 Nov 2019 //
PR NEWSWIRE
J&J taps kidney specialist Vifor for Invokana marketing help
04 Nov 2019 //
FIERCEP PHARMA
Mundipharma: Swissmedic reviewing licence extension
09 Oct 2019 //
BUSINESSWIRE
J&J’s Invokana gets lifeline with new kidney disease approval
02 Oct 2019 //
PMLIVE
Catabasis Pharma Announces the Phase 3 PolarisDMD Trial of Edasalonexent
30 Sep 2019 //
BIOSPACE
Novo`s Ozempic tops Invokana, Victoza in double head-to-head win
18 Sep 2019 //
FIERCE PHARMA
Novo`s Ozempic tops Invokana, Victoza in double head-to-head win
18 Sep 2019 //
FIERCE PHARMA
AstraZeneca aims to pump up Farxiga marketing after cardio outcomes study
06 Sep 2019 //
FIERCEPHARMA
EMA accepts license extension submission for Invokana and Vokanamet
24 Aug 2019 //
PHARMA TIMES
Mundipharma Announces the Licence Extension Sub for Invokana® Vokanamet®
21 Aug 2019 //
BUSINESSWIRE
Glenmark launches Remogliflozin combo in India; GeneCentric buys Select Immuno
19 Aug 2019 //
ENDPTS
Boehringer posts solid first half as business revamp beds in
02 Aug 2019 //
PMLIVE
Farxiga follows rival Zynquista to FDA rejection in Type 1 diabetes
16 Jul 2019 //
FIERCE PHARMA
FDA fast-tracks BI, Lilly`s Jardiance in chronic heart failure
26 Jun 2019 //
FIERCE PHARMA
J&J`s struggling Invokana slashes heart, kidney risks in latest trial win
11 Jun 2019 //
FIERCE PHARMA
AstraZeneca`s Farxiga scores in kidney outcomes study, cutting risks 47%
10 Jun 2019 //
FIERCE PHARMA
J&J’s Invokana closes on diabetic kidney disease approval
23 May 2019 //
PHARMAPHORUM
J&J’s Invokana closes on diabetic kidney disease approval
22 May 2019 //
PHARMAPHORUM
Researchers highlight risk of flesh-eating bacteria for SGLT2s
10 May 2019 //
FIERCE PHARMA
Janssen`s Invokana combo smashes primary & secondary endpoints in CKD
16 Apr 2019 //
PHARMAFILE
Data show J&J’s Invokana may slow or prevent CKD in diabetes patients
16 Apr 2019 //
PHARMA TIMES
J&J submits sNDA for Invokana after premature end to clinical trial
29 Mar 2019 //
PHARMA TIMES
Diabetes drugs in SGLT2 inhibitor class linked to pancreatitis genital infection
27 Mar 2019 //
PHARMABIZ
AZ`s Farxiga won its EU nod in Type 1. How will it fare at FDA?
27 Mar 2019 //
FIERCE PHARMA
J&J pays $500M in cash to grab rights to a new star cancer drug at argenx
03 Dec 2018 //
ENDPTS
Johnson & Johnson backs new Invokana CV nod with series of awareness tweets
14 Nov 2018 //
FIERCE PHARMA
AstraZeneca`s Farxiga lowers hospitalizations for heart failure by 17%
13 Nov 2018 //
FIERCE PHARMA
Johnson & Johnson bags long-awaited CV nod for diabetes drug Invokana
31 Oct 2018 //
FIERCE PHARMA
FDA Experts May Reconsider Diabetes Drug Safety Rules
26 Oct 2018 //
FORBES
Janssen`s Invokana (canagliflozin) Receives Approval in Europe
04 Oct 2018 //
EMA
Janssen-Cilag`s Invokana (canagliflozin) Receives Approval in Europe
04 Oct 2018 //
EMA
Johnson & Johnson Completes Divestiture of LifeScan to Platinum Equity
02 Oct 2018 //
PRESS RELEASE
How One Class Of Diabetes Meds May Lead To Flesh-Eating Genital Infections
01 Sep 2018 //
FORBES
EMA issues positive opinion to Janssen’s INVOKANA and VOKANAMET
09 Aug 2018 //
BIOSPECTRUM
PDL BioPharma Acquires Depomed`s Remaining 50% Interest in Royalties
02 Aug 2018 //
PR NEWSWIRE
